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Analytical techniques are critical for ensuring physical and chemical stability of a drug both for assessing the stability of drug 
molecules and for quantifying and identifying the drug content in products. We proposed the development of dry-powders of 
lipid-core nanocapsules containing dapsone and coated with chitosan, as well as, the analytical quantification of dapsone in dry-
powders with 1% and 2% (w/v) of leucine by high-performance liquid chromatography (HPLC). Size is the most relevant 
physicochemical property of nanoparticulated drug delivery systems. In this context, our results demonstrated that during the 
powders redispersion in water, could be observed that the mean particle diameters (DAP-LNC-CS-L1 and DAP-LNC-CS-L2) 
decreased with redispersion times increase. The spray-drying of the lipid-core nanocapsule formulations showed yields ranging 
from 58 ± 1.0 % (DAP-LNC-CS-L1) to 61 ± 1.5 % (DAP-LNC-CS-L2) indicating an efficient drying process. In this context, 
the analytical quantifications of dapsone in the dry powders of nanocapsules by HPLC showed that the dapsone content ranged 
from 92 ± 1.4% (DAP-LNC-CS-L2) to 95 ± 0.8% (DAP-LNC-CS-L1). Can be concluded that spray-drying process of DAP-
LNC-CS-L1 and DAP-LNC-CS-L2 formulations showed an efficient aqueous dispersion of nanocapsule powders and the 
analytical quantification of dapsone in spray-dryed powders were higher than 90%. 
Keywords: Dapsone; chitosan; lipid-core nanocapsules; dry-powder, analytical quantification. 
 
Introduction  
 
Dapsone (fig. 1) is a sulfone that has dual action 
mechanisms, as antimicrobial and anti-inflammatory (1). 
After oral administration, dapsone can be almost completely 
absorbed by intestine and has a bioavailability higher than 
86% (2,3). The main adverse effects, caused by its use, are 
methemoglobinemia, agranulocytosis and hemolytic anemia 
(4). However, the antiprotozoal effect of dapsone can be 
used for prophylaxis and prevention of recurrence in AIDS 
patients with pneumocystis jiroveci pneumonia and 
toxoplasmosis (1,3). 
 
 
 
 
Figure 1: Molecular structure of dapsone 
Chitosan is a biocompatible and biodegradable biopolymer 
that provides a cationic charge when dissolved in acetic acid 
(5). Due to its physicochemical properties, chitosan is used 
as carrier for various drugs and for controlled release 
applications. The potential of chitosan has been explored for 
oral and nasal administration of polar drugs due to their 
bioactivities. Chitosan associated with drug-containing 
formulations may exhibit dual therapeutic effects (6). 
The spray-drying technique is being increasingly applied to 
dry aqueous or organic suspensions and emulsions for food, 
chemical, pharmaceutical and biopharmaceutical industries. 
In the pharmaceutical industry spray-drying technique can 
be used to produce particle powders that can be 
administered by the pulmonary, nasal and oral routes (7,8). 
The drying process consists of a complex system in which 
several parameters can influence final product 
characteristics, however, studies of pre-formulation 
preparation are necessary to obtain products with adequate 
characteristics (9,10). 
In pharmaceutical research field, drugs analytical research, 
drug formulations, degradation products and impurities, and 
biological samples containing drugs is very important and 
necessary to analytical investigation. Analytical techniques 
are critical for ensuring the physical and chemical stability 
of drugs, for assessing the stability of drug molecules, for 
identifying and quantifying the drug content in the products 
(11,12). In the 1980s, HPLC methods first appeared for the 
pharmaceutical assay (united states pharmacopoeia, 1980) 
(13). High performance liquid chromatography (HPLC) is 
one of the most widely used techniques for analysis of drugs 
and formulations. In liquid chromatography, the selection of 
the detection method is critical to ensure that all components 
are detected (11,12). 
Our research group has been studying the use of spray-
drying technique to dry aqueous dispersions of polymer 
nanoparticles (14-16). The use of drying adjuvants such as 
silicon dioxide (17), manitol, hydroxypropylmethylcellulose 
(HPMC) (18) and leucine (19) is necessary to form 
microaggregate containing the polymer nanoparticles during 
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the process. In this way, we proposed the development of 
dry-powders of lipid-core nanocapsules containing dapsone 
and coated with chitosan assaying 1% and 2% (w/v) of 
leucine as drying adjuvant, as well as the detection of the 
analytical quantification of dapsone in dry-powders by 
HPLC. Each step of the study is represented in Figure 2. 
 
Figure 2: Schematic representation of the present study. 
 
Experimental 
Materials 
Poly(ԑ-caprolactone) (PCL) (Mn 10 kg mol
−1
, Mw 14 kg 
mol
−1
), chitosan low molecular weight (Mw 50–190 kg 
mol
−1
) and sorbitan monostearate (Span 60®) were obtained 
from Sigma-Aldrich (USA). Lipoid
®
 S75 (lecithin 75%) was 
purchased from Gerbras (Brazil). Polysorbate 80 and 
caprylic/capric triglyceride were acquired from Delaware 
(Brazil). Dapsone was obtained from DEG (Brazil). The 
chemicals and solvents used in this study were of analytical 
grade. 
Methods 
Preparation of the chitosan-coated dapsone-loaded lipid-
core nanocapsules  
The chitosan-coated dapsone-loaded lipid-core nanocapsules 
(DAP-LNC-CS) were prepared following the self-
assembling method as previously described by Cé et al., 
2016 (20). Thus, to obtain the DAP-LNC-CS suspension an 
organic phase containing sorbitan monostearate (0.040 g), 
caprylic/capric triglyceride (0.120g) poly(ε-caprolactone) 
(0.100 g) and dapsone (0.010 g) were dissolved in acetone 
(30 mL) at 40 °C. In addition, a solution containing Lipoid® 
S75 (0.06 g) was prepared and solubilized in ethanol (4 mL) 
and poured into the acetone solution. The organic phase was 
then injected into an aqueous solution (60 mL) containing 
polysorbate 80 (0.08 g) using a funnel. All organic solvents 
were removed from the suspension by rotary evaporator 
under reduced pressure at 40 ºC to 9 mL. The suspension (9 
mL) was coated after an interfacial reaction with chitosan by 
adding 1 mL of 1% (w/v) chitosan solution. This reaction 
was kept under magnetic stirring for 4 hours at room 
temperature. The DAP-LNC-CS suspension was 
characterized by laser diffraction, dynamic light scattering, 
potentiometry, zeta potential and HPLC, as previously 
reported (20). 
 
 
Spray-Drying of DAP-LNC-CS dispersion  
 
Prior the drying the final volume of the DAP-LNC-CS 
suspension was adjusted to 50 mL. For formulations drying, 
1% or 2% (w/v) of a leucine solution was added, and the 
mixture was fed into a Mini Spray-Dryer (Buchi, B-290, 
Switzerland) following the parameters: inlet temperature 
(120 ºC), outlet temperature (60ºC), Pump 15%, Nozzle 1 
and aspirator at 100%. After drying process, the formulation 
powders were removed from collection flask and stored in a 
vacuum desiccator. The formulation spray-dried powders 
were prepared in triplicate and renamed by DAP-LNC-CS-
L1 (1% leucine) and DAP-LNC-CS-L2 (2% leucine). 
 
 
Characterization of the nanocapsule spray-dried powder 
The yields (%) of spray-dried powders were calculated on 
the ratio between the sum of the weights of all solid 
components and experimentally obtained solid mass. To 
determine the water content, 1g of the samples were added 
in an infrared moisture analyzer (Ohaus MB45, USA) and 
evaluated at 105 °C for 1 minute. The diameter profiles of 
powders formulations after dispersion in water was 
evaluated using laser diffraction technique (Mastersizer 
2000, Malvern, UK). The powders were inserted in the wet 
dispersion unit of the instrument (2000 rpm) and data were 
recorded in predetermined time intervals (every 5 minutes) 
from 0 to 30 minutes (Mastersizer
®
 2000, Hydro SM). All 
measurements were performed in triplicate. 
 
 
Analytical Quantification of Dapsone in Spray-Powders 
 
The powders (12 mg) of the DAP-LNC-CS-L1 or DAP-
LNC-CS-L2 formulations were dispersed in a 10 ml 
volumetric flask containing a mixture of 
acetonitrile/water/acetic acid (40:59:1, v/v/v). Subsequently, 
the samples were extracted for 30 minutes in sonicator at 
room temperature and filtered (0.45 Μm, Millipore) for 
quantification by High Performance Liquid Chromatography 
(HPLC) (Shimadzu LC-20A system, CBM-20A system 
controller, SPD-M20A photodiode-array detector and a SIL-
20A auto-sampler, Tokyo, Japan). To quantification of the 
dapsone, the samples were injected (100 µl) with a flow rate 
of 0.7 ml min
−1
 and a retention time of 10 minutes using a 
lichrocart®250-4 and a lichrospher®100 RP-18 (5 µm) 
column. The mobile phase consisted of 
acetonitrile/water/acetic acid (40:59:1, v/v/v). The dapsone 
was detected at 293 nm. Our group (21) established the 
validation of the method for the quantification of dapsone. 
      
 
 
Scanning Electron Microscopy (SEM) 
 
The morphology of powders (DAP-LNC-CS-L1 and DAP-
LNC-CS-L2) were determined by scanning electron 
microscope at 10kv (Jeol Scanning Microscope, JSM-6060) 
in the microscopy and microanalysis center (CMM) of the 
Federal University of Rio Grande do Sul - UFRGS. Prior to 
SEM analysis, the powders were put on aluminum stubs 
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with carbon double-sided and were sputter-coated with a 
layer of gold. 
 
 
Statistical Analyzes 
The statistical analyzes of nanocapsules powders 
redispersion in different measurement times were evaluated 
in the software Statistical Analysis System (SAS, USA) 
using the ANOVA model fixed test with significance level of 
p < 0.05.  
Results and discussion 
 
Development and characterization of the nanocapsule 
spray-dried powder  
 
As briefly reported by our group (20), the DAP-LNC-CS 
suspension presented a unimodal size profile, positive zeta 
potential, acid pH and dapsone content close to 100% (20). 
The DAP-LNC-CS formulation showed a mean diameter 
[D4,3] of 129 ± 4 nm by laser diffraction (LD) and the 
hydrodynamic mean diameter (dh) was 117 ± 2 nm by 
dynamic light scattering (DLS), whereas polydispersity was 
0.88 ± 0.03 by LD and polydispersity index 0.14 ± 0.01 by 
DLS. The data for the new batch corroborate our previous 
report for this formulation (20). The chitosan-coated 
suspension of lipid-core nanocapsules containing dapsone 
were subjected to the drying process in order to produce a 
powdery product. For the analytical determination of 
dapsone in dry samples, the formulations were concentrated 
to a final volume of 50 mL. The macroscopic analysis of 
nanocapsules powder acquired using spray-dryer showed a 
fine white powder with a powdery appearance forming small 
particles corroborating with literature (21-23). 
Size is the most relevant physicochemical property of 
nanoparticulated systems, such as drug delivery systems 
(24). In this context, our results demonstrated that the mean 
diameters (D[4,3]) of nanocapsule spray-dried powder ranged 
from 0.493 ± 11 (µm) (DAP-LNC-CS-L2) to 0.726 ± 29 
(DAP-LNC-CS-L1) (µm) after 30 minutes of redispersion in 
water (Table 1). Within the early times of powders 
dispersion in water, we observed that the mean particle 
diameters (DAP-LNC-CS-L1 and DAP-LNC-CS-L2) were 
higher in relation to the subsequent time intervals (Table 1). 
The laser diffraction curves based on the volume of the 
particles showed multimodal profiles presenting populations 
in scales nanometric and micrometric for both formulations 
(DAP-LNC-CS-L1 and DAP-LNC-CS-L2) (Figure 3 and 4). 
Additionally, the polydispersity of diameters expressed by 
SPAN values ranged from 3.23 ± 112 (µm) (DAP-LNC-CS-
L2) to 5.00 ± 251 (µm) (DAP-LNC-CS-L1) after 30 minutes 
of dispersion in water (table 1). 
 
 
Figure 3: Size distribution curves as a function of time by laser 
diffraction of DAP-LNC-CS-L1 formulation. Note: 0 to 30 are the 
time intervals in minutes of sample dispersion in water after 
addition in the wet unit (Hydro 2000).  
 
Figure 4: Size distribution curves as a function of time by laser 
diffraction of DAP-LNC-CS-L2 formulation. Note: 0 to 30 are the 
time intervals in minutes of sample dispersion in water after 
addition in the wet unit (Hydro 2000). 
      
In this study, after five minutes of formulations redispersion 
in water, the mean diameter of DAP-LNC-CS-L1 and DAP-
LNC-CS-L2 decreased considerably. So to move forward, 
we use statistical analyzes to demonstrate this phenomenon. 
By means of statistical analyzes it showed that there were no 
significant differences in the redispersion times of the 
particles between 5 and 30 minutes (p < 0.05), it means that, 
in five minutes the powder of the formulations are already 
redispersed according to the statistical analyzes. After 
increasing the concentration of leucine, we observed lower 
mean diameter and polydispersity probably due to the 
coating of the nanocapsules surface by those molecules 
decreasing the tendency to form aggregates during the 
spray-drying process. The presence of chitosan, a 
polysaccharide, at the particle-water interface might increase 
the hydrogen bonding increasing the tendency to 
aggregation. In higher concentration, leucine was able to 
avoid partially this phenomenon. 
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Table 1. Laser diffraction mean diameter and polydispersity as a 
function of the time of powder dispersion in the wet unit. 
Formulations  
( n = 3) 
DAP-LNC-CS-L1           DAP-LNC-CS-L2 
Time interval 
of records 
D[4,3] (µm) SPAN (µm) D[4,3] (µm) SPAN (µm) 
0 5.156 ± 371 6.96 ± 1.113 0.781 ± 19 3.35 ± 800 
5 0.729 ± 24 5.18 ± 198 0.506 ± 10 3.26 ± 140 
10 0.723 ± 23 5.18 ± 220 0.497 ± 10 3.25 ± 133 
15 0.723 ± 24 5.14 ± 261 0.496 ± 12 3.24 ± 114 
20 0.723 ± 26 5.10 ± 267 0.494 ± 11 3.23 ± 118 
25 0.724 ± 26 5.04 ± 247 0.493 ± 11 3.23 ± 123 
30 0.726 ± 29 5.00 ± 251 0.493 ± 11 3.23 ± 112 
D[4,3]: volume-weighted mean diameter 
SPAN: polydispersity calculated by the difference between the 
diameters at percentiles 90 and 10, divided by the median diameter 
(based on the volume of the particles) 
 
According to Marchiori et al., 2011 (25) the particles 
recovered after redispersion presented similar average sizes 
compared to the original suspensions. The recoveries of 
particle diameters after being respread have already been 
reported in previous studies in nanoparticulate systems 
(17,26), so both studies were able to recover the particles 
after their aqueous dispersions. Particle size and high 
specific surface area provide suitable flow characteristics 
which are used for the purpose of improving post-dry 
properties (27). In this context, powders having different 
granulometries could be administered by means of a dry 
powder inhaler with an appropriate drug delivery along the 
respiratory tract (28).  The behavior of post-dry redispersion 
is evaluated by the wet diffraction technique to demonstrate 
that the powders from a dispersion time are able to recover 
their nanometric characteristics (29). 
 
Analytical Quantification and Yield of Dapsone in Spray-
Powders 
 
To prove that a drug is administered in a right place in 
appropriate amount, various analytical methods have been 
developed to detect and quantify the drugs in the samples 
(11,12). In this way, the analytical quantification of dapsone 
in the dry powder samples was determined according to a 
study reported in the literature and validated in accordance 
with International Conference on Harmonisation (ICH) (21). 
The dapsone content in the dry-powders of the nanocapsules 
formulations presented concentrations ranging from 15.9 ± 
0.44 mg. g 
-1
 (DAP-LNC-CS-L2) to 19.8 ± 0.14 mg. g 
-1
 
(DAP-LNC-CS-L1), which represented approximately 92 ± 
1.4% (DAP-LNC-CS-L2) and 95 ± 0.8% (DAP-LNC-CS-
L1) of the theoretical content [(17.3 mg. g 
-1
 (DAP-LNC-
CS-L2) and 20.8 mg. g 
-1
 (DAP-LNC-CS-L1), respectively], 
based on the analytical quantifications of dapsone in the dry 
powders of nanocapsules by HPLC. The percentage of the 
quantification of dapsone in the dry powder samples is in 
agreement with other drugs quantified in the nanoparticle 
powders (17,22,23). The representative chromatogram of 
formulations (DAP-LNC-CS-L1 and DAP-LNC-CS-L2), 
Free-DAP and Blank formulation (LNC-CS-L) are shown in 
Figure 5. 
 
 
 
Figure 5: Representative chromatogram of formulations DAP-
LNC-CS-L1 A), DAP-LNC-CS-L2 B), C) Free-DAP and D) Blank 
formulation (LNC-CS-L). 
 
The spray-drying process of the lipid-core nanocapsule 
formulations showed yields ranging from 58 ± 1.0% (DAP-
LNC-CS-L1) to 61 ± 1.5% (DAP-LNC-CS-L2). 
Additionally, the water loss after desiccation was below 2% 
[(DAP-LNC-CS-L2 - 1.30 ± 0.3%), (DAP-LNC-CS-L1 - 
1.33 ± 0.2%] indicating the efficiency of the drying process 
to remove water from the system. Powders prepared with 
adjuvants promote a better yield of the process, which is 
essential to maintain its properties and thus to become a 
good candidate for the treatment of diseases (14,17,23,24). 
Our data showed that there were no significant losses of 
drug during the drying process. Marchiori et al., 2011 (25) 
obtained a 95% content after drying the lipid nanocapsules 
of the lipid core containing tretinoin, which is a drug that 
undergoes photodegradation by ultraviolet light. Besides, 
another study reported that dry powders of lipid core 
nanocapsules containing tretinoin significantly improved the 
photostability of tretinoin compared to the formulation 
containing the unencapsulated drug (30). 
      
Scanning Electron Microscopy of the nanocapsule spray-
dried powder 
 
The scanning electron microscopy (SEM) images obtained 
from the formulations DAP-LNC-CS-L1 and DAP-LNC-
CS-L2 showed the presence of morphological agglomerates 
and an irregular surface of the particles according to Figure 
6. The SEM images found in our study corroborate with 
other dry powder images of spray-dried nanocapsules 
obtained by SEM (22,23,28).  
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Figure 6: Scanning electron microscopy (SEM) of the 
nanocapsules spray-dried powders: DAP-LNC-CS-L1 [(A) bar = 
20 µm and (B) bar = 10 µm], and DAP-LNC-CS-L2 [(C) bar = 20 
µm and (D) bar = 10 µm]. 
Conclusion 
 
Our results indicated that spray drying of the lipid core 
nanocapsules formulations prepared with dapsone and 
leucine (DAP-LNC-CS-L1 and DAP-LNC-CS-L2) exhibited 
an efficient aqueous dispersion of nanocapsule powders. The 
analytical quantification of dapsone in spray dried-powders 
revealed that the content of dapsone was higher than 92% in 
the powders. In this context, we have shown that the drying 
process for determination of dapsone analysis in spray-
powders nanocapsules is a viable and efficient tool.  
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